Alessandra Mingione Selected Research

thermozymocidin (myriocin)

1/2021	Myriocin modulates the altered lipid metabolism and storage in cystic fibrosis.
1/2020	Inhibition of Sphingolipid Synthesis as a Phenotype-Modifying Therapy in Cystic Fibrosis.
1/2020	Cystic Fibrosis Defective Response to Infection Involves Autophagy and Lipid Metabolism.
1/2019	Sphingolipid Synthesis Inhibition by Myriocin Administration Enhances Lipid Consumption and Ameliorates Lipid Response to Myocardial Ischemia Reperfusion Injury.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Alessandra Mingione Research Topics

Disease

5	Inflammation (Inflammations) 01/2022 - 01/2019
5	Nephrolithiasis 02/2015 - 05/2013
4	Cystic Fibrosis (Mucoviscidosis) 01/2021 - 01/2020
3	Chronic Renal Insufficiency 01/2022 - 07/2011
3	Proteostasis Deficiencies 06/2021 - 01/2020
3	Infections 01/2021 - 01/2020
3	Cardiovascular Diseases (Cardiovascular Disease) 08/2020 - 01/2015
3	Hyperparathyroidism 01/2018 - 07/2011
2	Parkinson Disease (Parkinson's Disease) 06/2021 - 07/2020
2	Primary Hyperparathyroidism 01/2017 - 02/2015
2	Neoplasms (Cancer) 01/2017 - 01/2015
2	Kidney Calculi (Kidney Stone) 02/2015 - 02/2014
1	COVID-19 10/2021
1	Dyslipidemias (Dyslipidemia) 01/2021
1	Pneumonia (Pneumonitis) 01/2020
1	Inborn Genetic Diseases (Disease, Hereditary) 01/2020
1	Type 2 Diabetes Mellitus (MODY) 08/2019
1	Insulin Resistance 08/2019
1	Myocardial Infarction 01/2019
1	Ischemia 01/2019
1	Myocardial Ischemia (Ischemic Heart Diseases) 01/2019
1	Infarction (Infarctions) 01/2019
1	Reperfusion Injury 01/2019
1	Necrosis 01/2019
1	Nephrocalcinosis 01/2017
1	Hypocalcemia 01/2017
1	Hypercalciuria 01/2017
1	Hyperphosphatemia 01/2017
1	Atherosclerosis 01/2016
1	Parathyroid Neoplasms (Parathyroid Neoplasm) 01/2015
1	Overweight 02/2014
1	Postmenopausal Osteoporosis 07/2010

Drug/Important Bio-Agent (IBA)

7	LipidsIBA 06/2021 - 01/2016
6	CalciumIBA 01/2017 - 07/2011
5	SphingolipidsIBA 01/2021 - 01/2019
4	thermozymocidin (myriocin)IBA 01/2021 - 01/2019
4	Calcium-Sensing ReceptorsIBA 01/2018 - 09/2013
3	Proteins (Proteins, Gene)FDA Link 06/2021 - 01/2017
2	CurcuminIBA 01/2022 - 08/2019
2	CeramidesIBA 06/2021 - 01/2020
2	Triglycerides (Triacylglycerol)IBA 01/2021 - 02/2014
2	CholesterolIBA 01/2021 - 01/2020
2	Phenylalanine (L-Phenylalanine)FDA Link 01/2020 - 01/2020
2	Pharmaceutical PreparationsIBA 01/2018 - 01/2015
2	Parathyroid Hormone (Parathormone)IBA 01/2017 - 01/2015
1	Antiviral Agents (Antivirals)IBA 10/2021
1	Adenine FDA LinkGeneric 10/2021
1	remdesivirIBA 10/2021
1	NucleosidesIBA 10/2021
1	SynucleinsIBA 06/2021
1	Fatty Acids (Saturated Fatty Acids)IBA 01/2021
1	Biomarkers (Surrogate Marker)IBA 12/2020
1	Ether (Diethyl Ether)IBA 12/2020
1	Cholesterol Esters (Cholesteryl Esters)IBA 12/2020
1	Phospholipids (Phosphatides)FDA LinkGeneric 12/2020
1	Glucagon-Like Peptide-1 ReceptorIBA 08/2020
1	Sarcoglycans (beta Sarcoglycan)IBA 08/2020
1	SugarsIBA 07/2020
1	Therapeutic UsesIBA 01/2020
1	AntioxidantsIBA 01/2020
1	Heat-Shock Proteins (Heat-Shock Protein)IBA 01/2020
1	Histones (Histone)IBA 01/2020
1	Vitamin D FDA LinkGeneric 01/2018
1	FilaminsIBA 01/2017
1	Messenger RNA (mRNA)IBA 01/2017
1	Aryldialkylphosphatase (Paraoxonase)IBA 01/2016
1	PolyphenolsIBA 01/2016
1	Cinacalcet (Sensipar)FDA Link 01/2015
1	Glucose (Dextrose)FDA LinkGeneric 02/2014
1	SodiumIBA 05/2013
1	Citric Acid (Citrate)FDA LinkGeneric 05/2013
1	Biological ProductsIBA 07/2011
1	Estrogens (Estrogen)FDA Link 07/2010

Therapy/Procedure

3	Therapeutics 01/2020 - 05/2013
1	Renal Dialysis (Hemodialysis) 08/2020
1	Percutaneous Coronary Intervention 01/2019
1	Thrombolytic Therapy 01/2019
1	Mediterranean Diet 02/2014
1	Secondary Prevention 05/2013
1	Conservative Treatment 07/2011